Reliance Life Sciences (RLS), part of India’s largest conglomerate, is expected to start a phase I clinical study from the original Covid-19 vaccine, report Rupali Mukherjee.
The subject expert committee, which suggested drug regulators on vaccines and new drugs, reviewing the company’s applications and learned to recommend it for approval on Thursday.
The formal nod to conduct a trial from the two doses is expected for the next few days, said the source to Ti.
The vaccine that is being developed is a covid-19 vaccine based on recombinant protein protein, and is expected to be launched in the first quarter of 2022.
The company began the development process last year, with a vaccine that entered the pre-clinical stage in the October vaccine was developed at the Navi Mumbai company, and is expected “Competitive price”.
Ludhiana: The police have submitted FIR to four identified and at least 40 unknown attackers…
Sonīpat / Ludhiana / Ambala: Actor Punjabi - Activist Activist Deep Sidhu, who died in…
PATIALA / MANSA / BARNALA: Attacking Prime Minister Narendra Modi and AAP National Convener Kejriawal,…
Jalandhar: BJP and AAM AAM AADMI parties are one party, Secretary General of the Ajay…
Ludhiana: Minister of Union Culture Meenakshi Lekhi while campaigning to support the BJP candidate from…
Machhiwara (Ludhiana): AAM AAM AADMI Party (AAP) Head of Punjab Candidate and Members of Parliament…